NeuroPace (NPCE) Depreciation & Amortization (CF) (2020 - 2026)
NeuroPace's quarterly Depreciation & Amortization (CF) came in at $60000.0 in Q1 2026, up 22.45% year-on-year from $49000.0 in Q1 2025, and down 25.0% quarter-over-quarter from $80000.0 in Q4 2025.
NeuroPace has reported Depreciation & Amortization (CF) for 7 years, with the latest figure at $60000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) rose 22.45% year-over-year to $60000.0; the trailing twelve-month figure through Mar 2026 stood at $340000.0 (up 17.24% YoY), and the FY2025 full-year result was $238000.0, up 19.0% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $60000.0, down from $80000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $100000.0 in Q2 2022, with the low at $40000.0 in Q4 2023.
- Average Depreciation & Amortization (CF) over 5 years is $78235.3, with a median of $87000.0 recorded in 2022.
- Year-over-year, Depreciation & Amortization (CF) sank 54.02% in 2023 and jumped 95.12% in 2025.
- Tracing NPCE's Depreciation & Amortization (CF) over 5 years: stood at $87000.0 in 2022, then slumped by 54.02% to $40000.0 in 2023, then gained by 2.5% to $41000.0 in 2024, then jumped by 95.12% to $80000.0 in 2025, then slipped by 25.0% to $60000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $60000.0 (Q1 2026), $80000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 123.40 Mn |
| 10 | NeuroPace | 558.86 Mn | 504.88 Mn | 18.05 Mn | 60,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60,000.00 |
| Mar 31, 2026 | 60,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Dec 31, 2025 | 80,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Sep 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Jun 30, 2025 | 100,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Mar 31, 2025 | 49,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Dec 31, 2024 | 41,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Sep 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Jun 30, 2024 | 100,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Mar 31, 2024 | 45,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Dec 31, 2023 | 40,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Sep 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Jun 30, 2023 | 100,000.00 |
| Mar 31, 2023 | 48,000.00 |
| Mar 31, 2023 | 48,000.00 |
| Dec 31, 2022 | 87,000.00 |
| Dec 31, 2022 | 87,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Sep 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Jun 30, 2022 | 100,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Mar 31, 2022 | 80,000.00 |
| Dec 31, 2021 | 79,000.00 |
| Dec 31, 2021 | 79,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Sep 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Jun 30, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Mar 31, 2021 | 100,000.00 |
| Dec 31, 2020 | 112,000.00 |
| Dec 31, 2020 | 112,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Sep 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Jun 30, 2020 | 100,000.00 |
| Mar 31, 2020 | 82,000.00 |
| Mar 31, 2020 | 82,000.00 |